Andreas Vente
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Efficacy and Safety of Finafloxacin Otic Suspension, 0.3% for the Treatment of Acute Otitis Externa: Results from two Phase III Randomized Clinical Studies.
Journal: The Annals of otology, rhinology, and laryngology
Published: May 29, 2026
Layering vaccination with antibiotic therapy results in protection and clearance of Burkholderia pseudomallei in Balb/c mice.
Journal: Infection and immunity
Published: January 30, 2024
In Vitro Activity of Finafloxacin against Panels of Respiratory Pathogens.
Journal: Antibiotics (Basel, Switzerland)
Published: April 03, 2023
Efficacy of finafloxacin in a murine model of inhalational glanders.
Journal: Frontiers in microbiology
Published: September 29, 2022
An Investigation into the Re-Emergence of Disease Following Cessation of Antibiotic Treatment in Balb/c Mice Infected with Inhalational Burkholderia pseudomallei.
Journal: Antibiotics (Basel, Switzerland)
Published: September 16, 2022
Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever.
Journal: Frontiers in microbiology
Published: August 18, 2021
The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Francisella tularensis Strain SchuS4.
Journal: Frontiers in microbiology
Published: February 14, 2019
Explorative Randomized Phase II Clinical Study of the Efficacy and Safety of Finafloxacin versus Ciprofloxacin for Treatment of Complicated Urinary Tract Infections.
Journal: Antimicrobial agents and chemotherapy
Published: November 11, 2017
Early Clinical Assessment of the Antimicrobial Activity of Finafloxacin Compared to Ciprofloxacin in Subsets of Microbiologically Characterized Isolates.
Journal: Antimicrobial agents and chemotherapy
Published: November 11, 2017
Population Pharmacokinetics of Finafloxacin in Healthy Volunteers and Patients with Complicated Urinary Tract Infections.
Journal: Antimicrobial agents and chemotherapy
Published: November 10, 2017
Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei.
Journal: Antimicrobial agents and chemotherapy
Published: January 20, 2017
Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections.
Journal: Antimicrobial agents and chemotherapy
Published: November 16, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026